This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer outcomes.
Women of all racial and ethnic groups 18 years of age or older
Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years
Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation)
Prior participation on clinical trials is allowed
Current receipt of interventional clinical trial participation
Stage IV (metastatic) cancer
Prior history of recurrence (except recurrence following ductal carcinoma in situ)
Inability to give informed consent
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator